Adult patients suffering fro appendicitis who are scheduled for open surgery(Open Appendicectomy)
Conditions
Interventions
Trade Name: MARCAINE
Pharmaceutical Form: Injection*
Sponsors
Derby Hospitals NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients aged over 18 years who are diagnosed with acute appendicitis and are scheduled for urgent open Appendicectomy Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: 1. Lack of consent 2. Patients with history of drug allergy to bupivacaine 3. Patients diagnosed with acute appendicitis scheduled for Laparoscopic Appendicectomy 4. Any skin infection over the lateral abdominal wall on the right side.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: The main objective is to evaluate the patient’s postoperative response with regards to the potential reduction in postoperative requirements for the amount of morphine at the first 24 hours in the cohort group compared to control group.;Secondary Objective: Assess the reduction in postoperative pain scores at 0 and 24 hours in the cohort group compared to control group.;Primary end point(s): The amount of morphine consumed in the first 24 postoperative hours in the cohort and in the control group. It will be measured using the patient’s treatment charts. | — |
Countries
United Kingdom
Outcome results
None listed